Evox Therapeutics teams with New York medical school to co-develop AAV vectors
Evox and the Icahn School of Medicine will develop gene delivery vectors for cardiomyocytes for heart disease treatments.
Evox and the Icahn School of Medicine will develop gene delivery vectors for cardiomyocytes for heart disease treatments.
What's Your Reaction?
